Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-03

FDA Approved: TOPAMAX — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Janssen's supplemental application for Topamax (topiramate) and updated the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topamax (Topiramate)

Snippet

SUPPL AP for TOPAMAX (TOPIRAMATE)